CrossrefInfokarte
The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status
Journal of Oncological Sciences · 2019-12 · 5 (3) · 85-89
DOI: 10.1016/j.jons.2019.08.003 ↗Abstract
Kein Abstract verfügbar.
EUVIMED